Autologous Gene Therapy for Artemis-Deficient SCID (Q62812906)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Autologous Gene Therapy for Artemis-Deficient SCID |
clinical trial |
Statements
A Phase I/II Feasibility Study of Gene Transfer for Artemis-Deficient Severe Combined Immunodeficiency (ART-SCID) Using a Self-Inactivating Lentiviral Vector (AProArt) to Transduce Autologous CD34 Hematopoietic Cells (English)
0 references
31 May 2018
0 references
June 2038
0 references
15
0 references
2 month
0 references